MyAverix Finance
F · Healthcare
hVIVO plc (CRO)
Diagnostics & Research
hVIVO plc (CRO) is listed on F in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-28, reported market cap is $50.14M, P/E ratio is 6.75, net margin is 9.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CRO
hVIVO plc (CRO) — FAQ
What is hVIVO plc's market cap?
hVIVO plc (CRO) has a reported market cap of $50.14M (data as of 2026-03-28).
What is CRO's P/E ratio?
The price-to-earnings (P/E) ratio for hVIVO plc (CRO) is 6.75 (data as of 2026-03-28).
Does hVIVO plc pay a dividend?
Dividend yield is not available in the current snapshot for hVIVO plc (CRO). Check the MyAverix Finance app for the latest dividend data.
What sector is hVIVO plc in?
hVIVO plc (CRO) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is CRO listed on?
CRO is listed on F.
What is hVIVO plc's net margin?
hVIVO plc (CRO) reports a net margin of 9.7% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.